Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.5K
Structure and Function of Platelets01:18

Structure and Function of Platelets

2.7K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

996
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
996

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Continuous platelet infusion in patient refractory to platelet transfusion : a retrospective study].

Revue medicale de Liege·2022
Same author

[Evolution of histocompatibility methods in organ transplantation: an update in 2022].

Revue medicale de Liege·2022
Same author

[Biological markers of inflammation : an update].

Revue medicale de Liege·2022
Same author

[Ferritinemia, a complex marker of iron metabolism].

Revue medicale de Liege·2021
Same author

[Hemophilia : a disease on the move].

Revue medicale de Liege·2020
Same author

[How to explore… Inherited platelet disorders].

Revue medicale de Liege·2019

Related Experiment Video

Updated: Jan 2, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K

[Inherited platelet disorders : clinical presentations and diagnostic algorithms].

R Harkati1, P Péters2, A Gothot3

  • 1Service de Biologie Clinique, CHU Liège, Belgique.

Revue Medicale De Liege
|December 14, 2019
PubMed
Summary
This summary is machine-generated.

Diagnosing rare inherited platelet disorders (IPDs) is challenging due to their varied symptoms and need for specialized tests. Early diagnosis is crucial to prevent harmful treatments and guide appropriate patient care.

Keywords:
Diagnostic algorithmDifferential diagnosisInherited platelet disorders

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

957
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.8K

Related Experiment Videos

Last Updated: Jan 2, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

957
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.8K

Area of Science:

  • Hematology
  • Genetics
  • Internal Medicine

Background:

  • Inherited platelet disorders (IPDs) are rare conditions with a broad clinical spectrum.
  • Late diagnosis of IPDs can result from their rarity and the need for specialized assays.
  • Early diagnosis is vital to prevent unnecessary and potentially harmful treatments.

Purpose of the Study:

  • To describe the diagnostic challenges of inherited platelet disorders.
  • To outline diagnostic algorithms for well-known IPDs.
  • To emphasize the importance of early IPD diagnosis.

Main Methods:

  • Review of clinical presentation and diagnostic workup for IPDs.
  • Description of specialized biological assays.
  • Presentation of diagnostic algorithms for common IPDs.

Main Results:

  • IPDs present with a wide range of hemorrhagic symptoms.
  • Specialized biological assays are essential for definitive diagnosis.
  • A systematic approach including history, physical exam, and initial lab tests can raise suspicion for IPD.

Conclusions:

  • Early diagnosis of IPDs is critical for effective patient management.
  • Referral to specialists is necessary for comprehensive diagnostic workup.
  • Understanding diagnostic algorithms aids in timely and accurate identification of IPDs.